Leone G, Wong YNS, Jones RJ, Sankey P, et al. Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study. J Clin Oncol 2025 Jul 28:JCO2402637. doi: 10.1200/JCO-24-02637.
PMID: 40720716